Try our Advanced Search for more refined results
Life Sciences - August, 2011
185 articles
- Baxter Sues Teva Over Propofol Indemnity Pact
- CareFusion Hits Hospira With Infusion System IP Suit
- FDA Urged To Ban J&J, Allergan Breast Implants
- Merck, Others Can't Dodge Jury's Chromium Verdict
- 2 Classen Patents Pass Bilski Test: Fed. Circ.
- Urology Group Settles Pa.'s Monopoly Claims
- 9th Circ. Sanctions Alioto Firm For Southwest Merger Row
- Merck Sues Ky. AG For Using Private Firm In Vioxx Suit
- Medicare Revision Doesn't Bar Contract Suit: Fed. Circ.
- Tainted Avastin Caused Eye Infections: FDA
- Acella Loses Bid To Nix False Ad Suit Over Vitamin Labels
- ACA Adaptation: Benefits And Coverage Summaries
- Merck Gets Bellwether Suit Slashed In Fosamax MDL
- Bankrupt Drug Tester Can Avoid Inova Lien: 8th Circ.
- Avanir Targets Wockhardt In Nuedexta Patent Blitz
- Ex-Pharma Holdings Execs Shell Out $2M To End Fraud Suit
- Drug Co. Seeks Quick Win On False Ad Claims In IP Suit
- Pfizer Settles Lipitor Patent Suit Against Dr. Reddy's
- Bristol-Myers Hit With IP Suit Over Data Encryption
- Shire Patent Suit Over Generic Intuniv Survives
- Mylan Loses Bid To Dismiss MS Drug Patent Suit
- Cedars-Sinai Can't Shake Doc's $4.7M Retaliation Award
- 3M Stakes New Forum In BacLite Blackmail Suit
- 11th Circ. Vacates Sanctions Against US In Shaygan Case
- Group Seeks Faster Label Updates For Generics Makers
- Allergan Sues Sandoz Over Lumigan Patents
- Private Equity Firm Offers $30M For Point Blank Assets
- CVS Asks High Court To Put W.Va. Drug Suit In Fed. Court
- Doc Says Tampa Firm Cut Him Out Of Genzyme Qui Tam
- Mylan's Generic Oracea Infringes Galderma IP: Judge
- Amgen Can't Dodge Kickback Claims In Aranesp Suit
- Merck's $32M Damages Nixed In Vioxx Wrongful Death Suit
- Shuttered Drug Co. Recalls Surgical Antiseptics
- UBS Didn't Earn $7.8M Transaction Fee: Stem Cell Co.
- Alcon Sues Apotex Over Generic Allergy Spray
- 2nd Circ. Nixes Wells Fargo Credit Agreement Row
- Teva Nixes Suit Against Apotex Over Parkinson's Drug
- Hansen Medical Securities Fraud Action Nixed
- Hologic Workers Win Initial Cert. In Overtime Action
- Medtronic Insulin Pumps Open To Cyberattack: Hacker
- Fed. Circ. Upholds Unigene Win Over Fortical Patents
- Michael Best Adds Polsinelli IP Attys In Chicago
- Kirkland Reps Baxter International In $380M Baxa Buy
- Concrete Co. Cops To Price-Fixing Scheme
- Mass. Asks To Join Healthpoint Fraud Suit Over Xenaderm
- US Sues To Freeze Assets In Weight Loss Clinic Fraud Case
- A Hindsight-Averse Application Of Lead Compound Case Law
- Sanofi Unit Snaps Up Indian OTC Business For $109M
- Par, UCB Pharma Settle Keppra Patent Fight
- High Doses Of Celexa May Cause Heart Disorder: FDA
- 5th Circ. Gives Stryker Knee Implant Action New Life
- Investor Hits Advanced Cell With $12M Stock Fraud Suit
- CAE Adds Medical Simulator Co. METI For $130M
- Orrick, Arent Rep Par Pharma In $410M Anchen Buy
- Judge Strips Ethypharm's Antitrust Suit Over TriCor IP
- Contractor Settles Civil Suit Over Fake Drug Test Claims
- GSK Drug Reps Ask High Court To Review OT Exemption
- Fed. Circ. Won't Revive Novartis Hemophilia Drug IP Suit
- The Product Malfunction Theory Lives On
- Novartis Settles Famvir Patent Dispute
- NBTY Unit Faces Class Action Over Joint Repair Claims
- Beckman Must Boost Lab Device Quality Practices: FDA
- Lessons From Stanford
- Attys See Writing On Wall In Authors' Copyright Suits
- Allergan Triumphs In Suits Over Generic Combigan
- Ex-Head Of Drug Testing Co. Cops To Billing Fraud
- Blankfein Retains Steptoe White Collar Veteran
- Walgreen Nabs Ex-United Air Top Atty
- Cravath Reps Aptuit In $410M Deal With Catalent
- CVS Agrees To Pay $2M Over Misleading Pricing Ads
- Masimo Hit With Oximetry Device IP Suit
- Universal May Have To Open Books For 'Smokey' Producer
- FTC Loses Lundbeck Baby Meds Fight Before 8th Circ.
- Cadence Sues Exela, Paddock To Block Generic Ofirmev
- Novartis, Apotex Resolve Suit Over Myfortic Patents
- Schering Says Judge Missed Key Facts In Sales Rep OT Suit
- Calif. Court Allows Class Pursuit In Listerine Ad Suit
- Class Status Sought In Express Scripts-Medco Deal Suit
- Blank Rome Scores IP Pro From Vorys
- Overhauling The 510(k) Process
- Smith & Nephew Hit With Knee Implant Patent Suit
- Ex-Lab Owner Admits To Selling Unapproved Stem Cells
- KVK Accuses Sunrise Of Stealing Employees, Trade Secrets
- Sandoz Wants Novo's Prandin Patent Ruled Invalid Again
- Allergan Sues Again To Block Generic Latisse
- Forest Labs Defeats Icahn In Proxy Fight
- Laying Claim To DNA
- Endo Strikes Mylan With Suit Over Generic Frova
- Panel Backs Most Allegra Ad Claims
- Pfizer Sues To Block Generic Lipitor
- P&G Denture Cream Suits To Stay Put In MDL
- Darvocet, Darvon Heart Risk Suits Consolidated
- Baxter Says Fresenius Owes $20M Over Dialysis Patent
- Staples Faces IP Suit Over Data Security Patent
- Medicis, Nycomed Settle Vanos Patent Dispute
- Abbott Targets Teva Over Latest Simcor ANDA
- Personalized Medicine, Patents And The Supreme Court
- Abbott Hit With 2 Suits Over Depakote Birth Defects
- Indirect Purchasers Certified In Wellbutrin Antitrust Suit
- Judge Boots Investor Class Action Over Feraheme Risks
- Pfizer Sues Merck, Schering Unit Over Lipitor Look-Alike
- FDA Unveils New Standards For Premarket Device Studies
- Investors Target BioMimetic Over Bone Graft Statements
- Pfizer's Viagra Patent Survives Teva Challenge
- Sanofi Says Sales Rep OT Suit Exploits FLSA Loophole
- Ex-FrontPoint Trader Cops To Receiving Insider Tips
- Fed. Circ. Denies Eon's Fee Bid In Skelaxin IP Case
- Body Science Aims To Ax Winston & Strawn From IP Case
- Feds Pan Ex-Point Blank CEO's Retrial Bid In $189M Scam
- Stryker Unit Dodges Zimmer's Sanctions Bid
- Ex-Nasdaq Exec Gets 3 1/2 Years For Insider Trades
- AstraZeneca Settles Idaho's AWP Suit For $2.5M
- CORRECTED: Ex-Nasdaq Exec Apologizes For Insider Trading
- GSK Wins False Patent Marking Suit Over Citrucel
- SEC Demands Info On Deere's Overseas Activities
- Avanir Sues Par, Actavis To Block Generic Nuedexta
- Inside Sorrell V. IMS Health
- Legal Implications Of New Cancer Causation Theories
- Ex-FrontPoint Trader Ends $30M SEC Insider Trading Suit
- Bayer, Lilly False Ad Row Over Pet Meds To Stay In NY
- Elan Beats Investor Fraud Claims Over Drug Prospects
- Vioxx Judge Reallocates $315M Counsel Award
- Credit Downgrade May Yield Ready-Made Fraud Defense
- Lilly, Hospira Settle Gemzar Patent Fight
- S&N Relator Seeks Sales Docs For Non-US Goods
- Pfizer Can't Shake Investor Suit Over Off-Label Marketing
- EU Patent Decision Admissible In Yaz Row, Bayer Says
- J&J Cuts Deal With US Over Risperdal Marketing Fraud
- Former Point Blank CEO To Cop To Tax Charges: Atty
- Cooley Snags 3 Life Sciences Partners From Seed IP
- Caliper, Carestream Settle Animal Imaging IP Row
- Wyeth, Sandoz Lay Down Swords In Effexor Patent Row
- Most Claims Stand In Securities Suit Over Vioxx Risks
- Zimmer Knee Implant Actions Merged Into MDL
- Celanese Unit Must Face Fiber Price-Fixing Suit
- Abbott Fights $3.5M Verdict In GSK Suit Over Norvir
- Forest Decision Does Little To Remove Exclusion Threat
- Canadian Class Certified In Suit Over Wyeth's Premarin
- US Probes Merck's Marketing Of 3 Drugs
- Teva Sued Over Generic HIV Drug
- FTC Says NY Pharmacy Choice Bill Could Curb Competition
- Pozen Wins Injunction On Generic Treximet
- Ex-Schering Sales Reps Prevail In FLSA Suit
- Hogan Lovells Snags Ex-Medtronic Atty With FDA Chops
- 1st Circ. Tosses Boston Scientific Securities Fraud Action
- Brigham And Women's Hospital Says It Lost Patient Info
- US Ends Bid To Oust Forest Labs CEO Solomon
- Canada Links Merck Drugs To Male Breast Cancer
- Ex-Orioles Player Settles Insider Trading Suit For $2.5M
- Ferring, Aventis Reach $20M Deal In DDAVP Antitrust Suit
- Illumina Asks Fed. Circ. To Revive Affymetrix IP Suit
- AstraZeneca Targets Hetero Over Nexium ANDA
- Surviving The 'Magic Microscope' Test
- Forest Labs Told To Turn Over Docs On CEO To Icahn
- Prescription Confidentiality Law And The Privacy Debate
- Baker Donelson Adds Ex-Bayer CropScience Patent Head
- High-Dose Diflucan May Cause Birth Defects: FDA
- Watchdog Attacks FDA Over Expert Conflicts Policy
- 8th Circ. Revives KV Antifungal Cream Trade Secrets Row
- 10th Circ. Revives Prozac Murder-Suicide Suit
- KemPharm Exec Can't Dodge Shire's Contract Claims
- Omnicom Courts Big Pharma With Synergy Deal
- WebMD Accused Of Hiding Ad Woes Before Stock Plunge
- Heightened Standard For The Entire Market Value Rule?
- Detecting Waste And Abuse In Health Care Spending
- Chinese Reverse Merger Co. Hyped 'Worthless' Stock: Suit
- Takeda Accused Of Hiding Diabetes Drug's Cancer Link
- Judge Trims Boehringer Sales Reps' OT Class Action
- 8th Circ. Denies 3rd Look At Catheter Antitrust Suit
- J&J Unit Seeks To Nix Listerine False Marketing MDL
- US Oncology Debtholders Seek $40M From McKesson Tie-Up
- Feds Fail To Keep FCA Docs Sealed In Omnicare Case
- Immunosyn Execs Hit With $20M Insider Trading Suit
- Fed. Circ. Sides With GSK, Others In Argatroban IP Row
- Gilead Tries To Nix Whistleblower's Retaliation Suit
- Cantel Expands GI Capabilities With $100M Byrne Deal
- ATS Corporate Liability After Kiobel
- FMC To Shell Out $2.1B For Dialysis Cos.
- Pfizer Unit Wants $65M More For Asbestos Ch. 11
- Mass. Sues J&J Unit Over Risperdal Off-Label Marketing
- Proskauer Rose Sued For $140M Over Flawed Tax Advice
- Pharmacies Fight $29B Express Scripts, Medco Deal
- Insurers Must Cover Birth Control At No Cost: HHS
- Is The Medical Device Review System Flawed?
- Bringing Consistency Back To Patent Litigation